Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $67,406 | 20 | 74.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,609 | 8 | 11.7% |
| Honoraria | $4,290 | 1 | 4.7% |
| Food and Beverage | $4,289 | 64 | 4.7% |
| Travel and Lodging | $3,974 | 17 | 4.4% |
| Education | $460.05 | 10 | 0.5% |
| Gift | $11.94 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $24,243 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $13,503 | 24 | $0 (2024) |
| CSL Behring | $11,753 | 16 | $0 (2024) |
| GENZYME CORPORATION | $9,558 | 6 | $0 (2022) |
| HEMA Biologics, LLC | $7,789 | 13 | $0 (2024) |
| APTEVO THERAPEUTICS INC | $5,730 | 7 | $0 (2019) |
| BIOVERATIV THERAPEUTICS INC. | $5,519 | 7 | $0 (2019) |
| Spark Therapeutics, Inc. | $4,152 | 7 | $0 (2019) |
| PFIZER INC. | $2,532 | 2 | $0 (2022) |
| MEDEXUS PHARMA, INC. | $2,500 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,044 | 10 | CSL Behring ($6,168) |
| 2023 | $2,801 | 11 | NOVARTIS PHARMACEUTICALS CORPORATION ($2,025) |
| 2022 | $11,636 | 9 | GENZYME CORPORATION ($5,783) |
| 2021 | $20,864 | 18 | Alnylam Pharmaceuticals Inc. ($12,067) |
| 2020 | $10,844 | 13 | CSL Behring ($5,124) |
| 2019 | $19,446 | 35 | Bayer HealthCare Pharmaceuticals Inc. ($7,443) |
| 2018 | $9,348 | 16 | BIOVERATIV THERAPEUTICS INC. ($5,351) |
| 2017 | $1,058 | 12 | Bayer HealthCare Pharmaceuticals Inc. ($515.74) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $78.74 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $73.64 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $72.20 | General |
| Category: Hematology | ||||||
| 10/12/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Hematology | ||||||
| 10/11/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Hematology | ||||||
| 06/20/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Consulting Fee | Cash or cash equivalent | $2,720.00 | General |
| Category: Genetic Disease | ||||||
| 03/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Jivi (Drug) | Consulting Fee | Cash or cash equivalent | $994.00 | General |
| Category: Hematology | ||||||
| 01/12/2024 | CSL Behring | HEMGENIX (Biological) | Consulting Fee | Cash or cash equivalent | $6,150.00 | General |
| Category: Hematology | ||||||
| 01/12/2024 | CSL Behring | HEMGENIX (Biological) | Travel and Lodging | Cash or cash equivalent | $17.97 | General |
| Category: Hematology | ||||||
| 12/08/2023 | CSL Behring | HEMGENIX (Biological) | Food and Beverage | In-kind items and services | $75.89 | General |
| Category: Hematology | ||||||
| 12/08/2023 | CSL Behring | HEMGENIX (Biological) | Food and Beverage | In-kind items and services | $63.86 | General |
| Category: Hematology | ||||||
| 12/08/2023 | CSL Behring | HEMGENIX (Biological) | Food and Beverage | In-kind items and services | $38.48 | General |
| Category: Hematology | ||||||
| 12/08/2023 | CSL Behring | HEMGENIX (Biological) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Hematology | ||||||
| 08/18/2023 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $57.51 | General |
| Category: Hematology | ||||||
| 08/18/2023 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $57.51 | General |
| Category: Hematology | ||||||
| 08/15/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $127.89 | General |
| Category: Rare Disease | ||||||
| 05/10/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.99 | General |
| 03/24/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: CELLT | ||||||
| 03/09/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | PROMACTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| Category: Oncology | ||||||
| 01/07/2023 | Octapharma USA, Inc. | NUWIQ (Biological) | Food and Beverage | In-kind items and services | $97.10 | General |
| Category: COAGULATION | ||||||
| 12/19/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $73.38 | General |
| 11/15/2022 | Novo Nordisk Inc | Rebinyn (Biological), Novoeight, NovoSeven | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Hemophilia | ||||||
| 06/06/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $79.99 | General |
| 05/23/2022 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $620.00 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 278 | 491 | $87,781 | $35,449 |
| 2022 | 7 | 255 | 441 | $76,741 | $30,809 |
| 2021 | 5 | 209 | 431 | $97,895 | $36,326 |
| 2020 | 9 | 239 | 389 | $85,585 | $29,935 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 113 | 203 | $28,489 | $13,895 | 48.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 92 | $24,472 | $8,388 | 34.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 121 | $22,385 | $7,490 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 35 | 42 | $9,282 | $4,082 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 21 | $1,953 | $837.03 | 42.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 12 | 12 | $1,200 | $757.00 | 63.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 117 | 214 | $30,548 | $15,034 | 49.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 87 | $23,142 | $6,901 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 54 | $9,990 | $2,965 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 20 | $4,537 | $2,158 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 18 | $4,284 | $1,345 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 24 | $2,232 | $1,055 | 47.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 12 | 12 | $1,200 | $831.86 | 69.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 12 | 12 | $808.00 | $519.26 | 64.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 108 | 210 | $30,597 | $15,395 | 50.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 166 | $44,156 | $13,355 | 30.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 32 | $16,512 | $5,021 | 30.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 12 | $2,769 | $1,390 | 50.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $3,861 | $1,164 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 79 | 165 | $22,929 | $9,438 | 41.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 83 | $22,078 | $6,817 | 30.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 23 | $11,868 | $3,736 | 31.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 33 | 33 | $8,778 | $3,386 | 38.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $6,322 | $1,980 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 16 | $5,616 | $1,650 | 29.4% |
About Dr. Danielle Nance, MD
Dr. Danielle Nance, MD is a Internal Medicine healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689718264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Nance, MD has received a total of $91,040 in payments from pharmaceutical and medical device companies, with $15,044 received in 2024. These payments were reported across 124 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($67,406).
As a Medicare-enrolled provider, Nance has provided services to 981 Medicare beneficiaries, totaling 1,752 services with total Medicare billing of $132,520. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Hematology
- Location Gilbert, AZ
- Active Since 02/16/2007
- Last Updated 06/20/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689718264
Products in Payments
- GIVLAARI (Drug) $20,723
- Jivi (Drug) $8,437
- IXINITY (Drug) $8,230
- SevenFact (Biological) $7,789
- HEMGENIX (Biological) $6,382
- ALPROLIX (Biological) $5,710
- Idelvion (Biological) $5,124
- NO PRODUCT DISCUSSED (Drug) $5,021
- PROMACTA (Drug) $2,025
- GIVLARRI (Drug) $1,920
- ONPATTRO (Drug) $1,600
- ALPROLIX (Drug) $329.38
- Multiple Products (Biological) $246.72
- Yescarta (Drug) $233.01
- ADVATE (Biological) $212.41
- Gammaplex (Drug) $160.56
- HEMLIBRA (Biological) $145.37
- ULTOMIRIS (Biological) $127.89
- Kyprolis (Biological) $121.85
- ELOCTATE (Drug) $97.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gilbert
Neil Sharma, M.d, M.D
Internal Medicine — Payments: $373,050
Richard Sue, Md, MD
Internal Medicine — Payments: $227,719
Dr. Abhimanyu Ghose, M.d, M.D
Internal Medicine — Payments: $98,848
Dr. Rachel Bond, M.d, M.D
Internal Medicine — Payments: $50,130
Dr. Matthew Ulrickson, M.d, M.D
Internal Medicine — Payments: $42,820
Dr. Wishwdeep Dhillon, M.d, M.D
Internal Medicine — Payments: $35,568